down arrow

Huadong Medicine Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000011S1
CNY
42.38
-1.42 (-3.24%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Huadong Medicine Co., Ltd.
Why is Huadong Medicine Co., Ltd. ?
1
With ROE of 15.20%, it has a very attractive valuation with a 3.05 Price to Book Value
  • Over the past year, while the stock has generated a return of 17.84%, its profits have risen by 16.4% ; the PEG ratio of the company is 1.2
  • At the current price, the company has a high dividend yield of 2.3
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Huadong Medicine Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Huadong Medicine Co., Ltd. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Huadong Medicine Co., Ltd.
-100.0%
1.11
31.92%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
4.69%
EBIT Growth (5y)
7.58%
EBIT to Interest (avg)
36.90
Debt to EBITDA (avg)
0.10
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
1.57
Tax Ratio
17.97%
Dividend Payout Ratio
46.39%
Pledged Shares
0
Institutional Holding
0.05%
ROCE (avg)
17.22%
ROE (avg)
14.25%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
3.05
EV to EBIT
16.40
EV to EBITDA
13.50
EV to Capital Employed
3.05
EV to Sales
1.71
PEG Ratio
1.23
Dividend Yield
2.25%
ROCE (Latest)
18.59%
ROE (Latest)
15.20%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
ROCE(HY)

Highest at 15.49%

RAW MATERIAL COST(Y)

Fallen by -4.86% (YoY

CASH AND EQV(HY)

Highest at CNY 8,988.42 MM

NET SALES(Q)

Highest at CNY 10,678.52 MM

-6What is not working for the Company
INTEREST(Q)

At CNY 25.92 MM has Grown at 77.45%

DEBT-EQUITY RATIO (HY)

Highest at 7.98 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.48%

OPERATING PROFIT(Q)

Lowest at CNY 1,130.4 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 10.59 %

Here's what is working for Huadong Medicine Co., Ltd.
Net Sales
Highest at CNY 10,678.52 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Cash and Eqv
Highest at CNY 8,988.42 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -4.86% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Huadong Medicine Co., Ltd.
Interest
At CNY 25.92 MM has Grown at 77.45%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit
Lowest at CNY 1,130.4 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 10.59 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio
Highest at 7.98 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio
Lowest at 3.48%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."